New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates.
Ontology highlight
ABSTRACT: The transforming growth factor beta (TGF-β) signaling is fundamental for correct embryonic development. However, alterations of this pathway have been correlated with oncogenesis, tumor progression and sustaining of cancer stem cells (CSCs). Cripto-1 (CR-1) and Nodal are two embryonic proteins involved in TGF-β signaling. Their expression is almost undetectable in terminally differentiated cells, but they are often re-expressed in tumor cells, especially in CSCs. Moreover, cancer cells that show high levels of CR-1 and/or Nodal display more aggressive phenotypes in vitro, while in vivo their expression correlates with a worse prognosis in several human cancers. The ability to target CSCs still represents an unmet medical need for the complete eradication of certain types of tumors. Given t
SUBMITTER: Arboretto P
PROVIDER: S-EPMC8345935 | biostudies-literature | 2021 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA